This information is disseminated under the sponsorship of the U.S. Department of Transportation
in the interest of information exchange.
The United States Government assumes no Liability for the contents or use thereof.
Benzodioxolylbutanamine (1,3-) |
| Description |
BDB produces entactogenic, MDMA-like effects. While pleasant and euphoric, BDB is also fairly sedating and some users feel that the lack of stimulant effect makes it less enjoyable than other similar drugs. Additional side effects associated with BDB include nystagmus and dizziness. |
| Therapeutic Low |
0.0000 |
| Therapeutic High |
0.0000 |
| Units |
ug/mL |
| Specimen |
P |
| Half Life Low |
0.00 |
| Half Life High |
0.00 |
| VOD Low |
0.00 |
| VOD High |
0.00 |
| Toxic Level |
0.000 |
| Lethal Level |
0.000 |
| Plasma to Whole Blood ratio |
0.00 |
| Warnings |
Warnings - may impair mental and/or physical ability required for the performance of potentially hazardous tasks (e.g., driving, operating heavy machinery). |